The Eonis Q system simplifies and streamlines molecular testing for SMA and SCID with an innovative dry chemistry workflow, comprising the Eonis Q96 instrument, the Eonis SCID-SMA kit and dedicated EASI software.

EONIS Q384 is a real-time PCR instrument with possibility to integrate into automation systems. The EONIS Q instrument uses dried blood spot samples (DBS samples) punched from DBS cards. The DNA from the punches are extracted with a simple extraction protocol. No wash steps are required, only a 20 minute-incubation in a simple incubator.

The EONIS Q system simplifies and streamlines molecular testing for SMA and SCID with an innovative workflow, comprising the EONIS™ Q96 instrument, the EONIS™ SCID-SMA kit and dedicated EONIS™ EASI™ software. Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada.

2023年11月27日 · The EONIS Q system simplifies and streamlines molecular testing for SMA and SCID with an innovative workflow, inclusive of the EONIS™ Q96 instrument, the EONIS™ SCID-SMA kit and dedicated EONIS™ EASI™ software.

A complete system for SMA, SCID & XLA screening, from sample to results. The design of the EONIS assay and system enable automation without compromising the sample traceability from punch to result.

2023年12月1日 · Revvity has launched its EONIS Q system for faster and simplified newborn molecular screening of spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID), the company announced. According to Revvity, this easy-to-use platform reduces the complexity and costs for laboratories, so they can expand newborn screening capabilities.

2023年11月28日 · Revvity has introduced a CE-IVD declared platform, EONIS Q, to enable molecular testing in newborns for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA). By utilising the EONIS Q96 instrument, EONIS SCID-SMA kit, and EONIS EASI software, the system helps simplify and streamline molecular testing for both conditions.

The Eonis Q96 (Manufacturer: Revvity, Inc.) is a quantitative real-time PCR thermal cycler for analyses in 96-well format with accurate real time results. The 96-well PCR plate with a sample volume between 10 and 100 µL can be conveniently …

2023年11月27日 · Revvity has launched its new EONIS Q system, a CE-IVD declared platform enabling laboratories to adopt molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

2023年11月27日 · The EONIS Q system simplifies and streamlines molecular testing for SMA and SCID with an innovative workflow, inclusive of the EONIS™ Q96 instrument, the EONIS™ SCID-SMA kit and dedicated EONIS™ EASI™ software.